Private equity firm Celtic Pharma is launching two new funds worth $1.5 billion in total, to invest in development-stage biotech companies and products.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.